Wordt geladen...
Efficiency and Safety of Proprotein Convertase Subtilisin/Kexin 9 Monoclonal Antibody on Hypercholesterolemia: A Meta-Analysis of 20 Randomized Controlled Trials
BACKGROUND: Proprotein convertase subtilisin/kexin9 (PCSK9) monoclonal antibody significantly reduces low-density lipoprotein cholesterol level in patients with hypercholesterolemia. The goal of this study was to review recently reported randomized controlled trials to investigate the therapeutic ef...
Bewaard in:
| Gepubliceerd in: | J Am Heart Assoc |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599534/ https://ncbi.nlm.nih.gov/pubmed/26077586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.115.001937 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|